Evaluation of Pediatric COVID-19 Screening Process in a Tertiary Hospital of Indonesia

Objectives. To identify parameters that can improve the effectiveness of COVID-19 screening in the pediatric population according to the demographic, clinical, and epidemiological characteristics of pediatric patients screened for COVID-19 at our hospital. Methods. A cross-sectional study of suspect...

Full description

Bibliographic Details
Published in:Journal of Tropical Medicine
Main Authors: Nastiti Kaswandani, Nina Dwi Putri, Madeleine Ramdhani Jasin, Tartila Tartila, Henny Adriani Puspitasari, Wahyuni Indawati, Mulya Rahma Karyanti, Ari Prayitno, Niken Wahyu Puspaningtyas, Yogi Prawira, Ajeng Kartika Ayu Putri, Hana Anindya Indana, Aryono Hendarto
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2022
Subjects:
Online Access:https://doi.org/10.1155/2022/6194776
https://doaj.org/article/43b0f8a0470e4f729eb5611501fc0342
Description
Summary:Objectives. To identify parameters that can improve the effectiveness of COVID-19 screening in the pediatric population according to the demographic, clinical, and epidemiological characteristics of pediatric patients screened for COVID-19 at our hospital. Methods. A cross-sectional study of suspected and confirmed pediatric patients (0–18 years old) with COVID-19 using data from the electronic medical records of Dr. Cipto Mangunkusumo Central Hospital from March to December 2020. Results. From 1,018 data of suspected COVID-19 pediatric patients, there were 94 (9.2%) confirmed cases of COVID-19. The proportions of children with travel history (p=0.022), positive contact history (p<0.001), fever ≥38°C (p=0.034), cough (p=0.038), and abdominal pain (p=0.022) were significantly higher in the confirmed COVID-19 group compared to the non-COVID-19 group. Conclusions. A majority of the confirmed COVID-19 pediatric patients have travel and positive contact history, along with symptoms of fever, cough, and abdominal pain. However, these are nonspecific symptoms that may also be misdiagnosed as other diseases. Improving access and turnaround time of the RT-PCR test is mandatory, as no specific screening variables have been identified.